This is a good time to look at biotech since it tends to hold up relatively well during bear markets and recessions, says Andrew Wang. He and David Nierengarten discuss the biotech sector. They talk about how Wedbush has outperform ratings for ARGX, GTHX, MRSN, TSVT, and SRRK. They also go over why the biotech sector could be a defensive play. Next, they mention investing strategies for biotech stocks. Tune in to find out more about the stock market today.
13 Jan 2023
Trading 360
03 Apr 2023
Next Gen Investing
18 Apr 2023
The Watch List
27 Apr 2023
Market On Close
05 Jun 2023
Morning Trade Live
09 Mar 2023
Trading 360
05 Apr 2023